Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function

Míreanna comhchosúla

• Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
  de réir: Bafadhel, M, et al.
  Foilsithe / Cruthaithe: (2018)
• Mepolizumab for eosinophilic COPD
  de réir: Sciurba, F, et al.
  Foilsithe / Cruthaithe: (2018)
• Mepolizumab for eosinophilic chronic obstructive pulmonary disease
  de réir: Pavord, I, et al.
  Foilsithe / Cruthaithe: (2017)
• Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
  de réir: Pavord, I, et al.
  Foilsithe / Cruthaithe: (2017)
• Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
  de réir: Gunsoy, N, et al.
  Foilsithe / Cruthaithe: (2017)